DrugCompare.Com? Consumer Demand For Information Hits DTC Boundaries
Executive Summary
While the public is increasingly interested in comparing the effectiveness of prescription drugs, pharmaceutical companies are hard pressed to provide such information without running afoul of FDA's Division of Drug Marketing, Advertising and Communications
You may also be interested in...
Advertisements For Flu Treatments Reflect Pharma’s Shift Toward New Media
A combination of a weak flu season and a shift in marketing strategies has resulted in fewer traditional direct-to-consumer advertising campaigns in the past two years by the leading manufacturers of flu medications
Advertisements For Flu Treatments Reflect Pharma’s Shift Toward New Media
A combination of a weak flu season and a shift in marketing strategies has resulted in fewer traditional direct-to-consumer advertising campaigns in the past two years by the leading manufacturers of flu medications
DTC Risk Disclosures Examined By FDA; Do Minor Risks Swamp Major Ones?
FDA will evaluate how the presence of minor safety risks in the brief summary of print direct-to-consumer advertisements impacts consumer comprehension of major risks